DTC Advertising Does Not Elicit Patient Requests For Prescriptions, Study Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The study “challenges many of the assumptions of both academic and public policy critics of DTC,” CommonHealth concludes.
You may also be interested in...
PhRMA DTC Principles Call For End Of Reminder Ads
Independent review panel will be established to handle complaints about pharmaceutical advertising.
Sen. Frist's Diagnosis On DTC: GAO Report, Two-Year Moratorium For New Drugs
Majority Leader Frist requests Government Accountability Office examine FDA's oversight of direct-to-consumer ads and their impact on drug usage and costs. The senator also requests drug companies voluntarily restrict DTC ads during the first two years a product is on the market.
Celgene To Submit Revlimid Phase III Special Protocol Assessment For CLL To FDA Shortly
Firm notes strong uptake of the product in 2006, as well as more than $400 million in Thalomid sales for the year during earnings call.